BRIEF published on 09/23/2024 at 08:20, 2 months 28 days ago Tissue Regenix Group Achieves First Pre-Tax Profit Market Expansion Pre-tax Profit Tissue Regenix Soft Tissue Repair Bone Repair
BRIEF published on 09/23/2024 at 08:20, 2 months 28 days ago Tissue Regenix Group réalise son premier bénéfice avant impôts Bénéfice Avant Impôts Expansion Du Marché Tissu Regenix Réparation Des Tissus Mous Réparation Osseuse
PRESS RELEASE published on 09/23/2024 at 08:15, 2 months 28 days ago Hardman & Co Research on Tissue Regenix (TRX): Maiden pre-tax profit Hardman & Co Research reports on Tissue Regenix (TRX) achieving maiden pre-tax profit. TRX focuses on soft tissue and bone repair technologies, showing strong growth and profitability Hardman & Co Research Pre-tax Profit Tissue Regenix Soft Tissue Repair Bone Repair
BRIEF published on 06/25/2024 at 10:48, 5 months 26 days ago Decline of UK Life Sciences Sector Raises Concerns Investment Tissue Regenix Institutional Support UK Life Sciences Healthcare Index
BRIEF published on 06/25/2024 at 10:48, 5 months 26 days ago Le déclin du secteur britannique des sciences de la vie suscite des inquiétudes Investissement Régénix Des Tissus Sciences De La Vie Au Royaume-Uni Indice De Santé Appui Institutionnel
PRESS RELEASE published on 06/25/2024 at 10:43, 5 months 26 days ago Hardman & Co Insight: Survival of the UK life sciences sector Hardman & Co Research presents insights on the survival of the UK life sciences sector, highlighting challenges and opportunities for institutional investors. Discover more in the full report Investment Opportunities Hardman & Co Research Institutional Investors UK Life Sciences Sector Healthcare Stocks
BRIEF published on 04/10/2024 at 08:20, 8 months 11 days ago Hardman & Co Research Highlights Tissue Regenix's Impressive Growth Streak EBITDA Growth Tissue Regenix DCELL® BioRinse®
BRIEF published on 04/10/2024 at 08:20, 8 months 11 days ago Hardman & Co Research met en évidence la séquence de croissance impressionnante de Tissue Regenix Croissance BAIIA DCELL® BioRinse® Régénix Des Tissus
PRESS RELEASE published on 04/10/2024 at 08:15, 8 months 11 days ago Hardman & Co Research on Tissue Regenix (TRX): Six consecutive periods of >20% growth Hardman & Co Research highlights Tissue Regenix (TRX) with six consecutive periods of >20% growth, backed by strong commercial partners and expansion plans Hardman & Co Research Growth Investments Tissue Regenix EBITDA-positive
PRESS RELEASE published on 09/18/2023 at 11:40, 1 year 3 months ago Hardman & Co Research on Tissue Regenix (TRX): Continuing postive momentum 1H'23
Published on 12/21/2024 at 01:30, 17 hours 13 minutes ago Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 13 minutes ago iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 18 hours 38 minutes ago Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/20/2024 at 23:30, 19 hours 13 minutes ago Boron One Announces Extension to Early Warrant Exercise Incentive Program
Published on 12/21/2024 at 00:51, 17 hours 51 minutes ago Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 17 hours 57 minutes ago EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 32 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 23 hours 47 minutes ago CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/21/2024 at 12:17, 6 hours 25 minutes ago AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 6 hours 25 minutes ago AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 17:55, 1 day ago Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024
